Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease

about

Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease

Item

http://www.wikidata.org/entity/Q35626544

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@ast

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@en

type

Item

label

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@ast

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@en

prefLabel

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@ast

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@en

P1476

Mineralocorticoid receptor blo ...... emia in chronic kidney disease

@en

P2093

B Pitt

http://www.w3.org/2001/XMLSchema#string

E Ritz

http://www.w3.org/2001/XMLSchema#string

P2860

A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

Vascular calcification--is aldosterone a culprit?

Aldosterone synthase inhibition in humans

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor

Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?

Dietary potassium intake and mortality in long-term hemodialysis patients.

A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients

P304

464-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFT084

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271346079

http://www.w3.org/2001/XMLSchema#string

P698

26120440

http://www.w3.org/2001/XMLSchema#string

P932

4438399

http://www.w3.org/2001/XMLSchema#string